摘要
在神经退行性疾病中,身体有进行性退行性变,导致神经细胞死亡。在这种状态下,患者每天都会患有精神虚弱、痴呆和共济失调。阿尔茨海默病(AD)是最常见的不可逆神经退行性脑疾病,主要影响65岁以上的人。许多类型的研究表明,AD的主要罪魁祸首是一种被称为淀粉样蛋白的(39-43)氨基酸肽的聚集形式。淀粉样蛋白(Aβ)是由分泌酶和分泌酶对较大的糖蛋白的作用产生的。Gamma(γ)分泌酶是一种膜内蛋白酶复合物,它可以切割单通道跨膜蛋白、淀粉样前体蛋白和Notch。γ-分泌酶复合物包含早老素、早老素增强因子2、前咽缺陷因子1和尼卡斯汀。任何早老素-1的突变或γ分泌酶直接或间接切割淀粉样前体蛋白都与AD相关。因此,预防这种酶是治疗AD的溶液之一。在这篇文章中,我们讨论了γ-分泌酶复合物及其抑制剂,可以有助于预防AD。
关键词: 神经退行性疾病、阿尔茨海默病、淀粉样蛋白、γ分泌酶、Notch、早衰老素、前咽缺陷-1、尼卡斯特蛋白、淀粉样前体蛋白。
图形摘要
Current Drug Targets
Title:Insight γ-Secretase: Structure, Function, and Role in Alzheimer’s Disease
Volume: 22 Issue: 12
关键词: 神经退行性疾病、阿尔茨海默病、淀粉样蛋白、γ分泌酶、Notch、早衰老素、前咽缺陷-1、尼卡斯特蛋白、淀粉样前体蛋白。
摘要: In neurodegenerative disorders, there is a progressive degeneration of the body, leading to the death of nerve cells. In this state, a patient gets affected day by day with mental weakness, dementia, and ataxia. Alzheimer’s disease (AD) is the most common irreversible neurodegenerative brain disorder mainly affecting people over the age of 65. Many types of research suggest that the main culprit for AD is the aggregated form of a (39-43) amino acid peptide called amyloid beta. Amyloid beta (Aβ) is generated by the action of beta-secretase and gamma-secretase on the larger glycoprotein. Gamma (γ) secretase is an intra-membrane protease complex that cleaves the single-- pass transmembrane protein, the amyloid precursor protein, and Notch. The γ-secretase complex contains presenilin, presenilin enhancer-2, anterior pharynx defective-1, and nicastrin. Any mutation in presenilin-1 or the cleavage of amyloid precursor protein by γ-secretase directly or indirectly is associated with AD. Therefore, the prevention of this enzyme is one of the solutions for AD. In this article, we discuss the γ-secretase complex and its inhibitors that can contribute to the prevention of AD.
Export Options
About this article
Cite this article as:
Insight γ-Secretase: Structure, Function, and Role in Alzheimer’s Disease, Current Drug Targets 2021; 22 (12) . https://dx.doi.org/10.2174/1389450121999201230203709
DOI https://dx.doi.org/10.2174/1389450121999201230203709 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
A Review of Natural and Synthetic Antioxidants Important for Health and Longevity
Current Medicinal Chemistry Potential Disease Targets for Drugs that Disrupt Protein - Protein Interactions of Grb2 and Crk Family Adaptors
Current Pharmaceutical Design Beyond Oncolytic Virotherapy: Replication-Competent Retrovirus Vectors for Selective and Stable Transduction of Tumors
Current Gene Therapy HIV-1 Tat-Mediated Calcium Dysregulation and Neuronal Dysfunction in Vulnerable Brain Regions
Current Drug Targets Organ- and Cell-Type Specific Delivery of Kinase Inhibitors: A Novel Approach in the Development of Targeted Drugs
Current Molecular Pharmacology Approaches to Target Profiling of Natural Products
Current Medicinal Chemistry Intracellular Fate of Peptide-Mediated Delivered Cargoes
Current Pharmaceutical Design Editorial (Hot Topic:Recent Advance in the Studies of Beta-glucans for Cancer Therapy)
Anti-Cancer Agents in Medicinal Chemistry Natural Sirtuin Modulators in Drug Discovery: A Review (2010 -2020)
Current Medicinal Chemistry A Review on Antiproliferative and Apoptotic Activities of Natural Honey
Anti-Cancer Agents in Medicinal Chemistry Mevalonate Kinase Deficiency: Disclosing the Role of Mevalonate Pathway Modulation in Inflammation
Current Pharmaceutical Design Higher Placental Anti-Inflammatory IL-10 Cytokine Expression in HIV-1 Infected Women Receiving Longer Zidovudine Prophylaxis Associated with Nevirapine
Current HIV Research Old Tyrosine Kinase Inhibitors and Newcomers in Gastrointestinal Cancer Treatment
Current Cancer Drug Targets Phenothiazines and Related Drugs as Multi Drug Resistance Reversal Agents in Cancer Chemotherapy Mediated by p-glycoprotein
Current Cancer Therapy Reviews Synthetic Src-Kinase Domain Inhibitors and Their Structural Requirements
Anti-Cancer Agents in Medicinal Chemistry RNA Binding Protein/RNA Element Interactions and the Control of Translation
Current Protein & Peptide Science A Combination of Two Antioxidants (An SOD Mimic and Ascorbate) Produces a Pro-Oxidative Effect Forcing Escherichia coli to Adapt Via Induction of oxyR Regulon
Anti-Cancer Agents in Medicinal Chemistry DNA Mismatch Repair Deficiency, Resistance to Cancer Chemotherapy and the Development of Hypersensitive Agents
Current Topics in Medicinal Chemistry State of the Art in African Trypanosome Drug Discovery
Current Topics in Medicinal Chemistry Reviewing Colchicaceae Alkaloids – Perspectives of Evolution on Medicinal Chemistry
Current Topics in Medicinal Chemistry